Welcoming a newborn into the world is a magical moment, but it’s also one that comes with its share of challenges. For many parents, neonatal jaundice—a condition characterised by a yellowish tint to a baby’s skin and eyes—can be an unexpected concern. While it’s common and often harmless, certain factors like low birth weight and premature birth can increase the risk of neonatal jaundice. At Cloudnine, we’re harnessing the power of technology to predict and prevent such risks, ensuring every baby gets the best start in life.
Nationally neonatal jaundice affects nearly 60% of full-term newborns and a staggering 80% of preterm babies in their first week of life. The condition occurs due to elevated bilirubin levels— a natural byproduct of red blood cell breakdown. While mild cases resolve on their own, severe jaundice in newborns can lead to complications, making early detection and intervention critical.
1. Gestational Age: Preterm infants (<37 weeks) have underdeveloped livers, which are less efficient at processing bilirubin.
2. Birth Weight:
• SGA (Small for Gestational Age): Babies born smaller than expected for their gestational age face higher risks due to limited fat stores and increased bilirubin production.
• AGA (Appropriate for Gestational Age): These babies generally have a lower risk, benefiting from balanced growth.
• LGA (Large for Gestational Age): Risk factors often stem from maternal conditions like diabetes, which can cause higher red blood cell counts, increasing bilirubin levels.
The graph would reveal percentage of neonatal jaundice cases in Cloudnine born babies compared to average percentage across the world and country. The preterm and SGA babies have the highest incidence of jaundice, reinforcing the need for vigilant care and timely interventions.
At Cloudnine, we don’t just deliver babies—we deliver peace of mind.
Here’s how we’re making a difference:
By analysing maternal and neonatal health data, our advanced analytics help identify trends and potential risk factors for low birth weight and jaundice. These insights enhance our approach to newborn care, allowing us to refine protocols and preventive strategies.
Preterm and low birth weight babies require extra attention, and Cloudnine’s specialised care ensures they get it:
• Non-invasive bilirubin monitoring tools help us detect jaundice in newborns before it becomes severe.
• Targeted phototherapy for newborns protocols are customised to meet the unique needs of preterm and SGA infants.
We believe informed parents are empowered parents. That’s why we offer educational sessions on: • Recognising early signs of jaundice.
• The importance of frequent feeding to flush bilirubin from the body.
• When to seek medical attention.
Our Neonatal Intensive Care Units are equipped with the latest technology, including advanced phototherapy for newborns systems and exchange transfusion capabilities, to manage even the most severe cases of jaundice.
For expecting parents, understanding how gestational age and birth weight contribute to the risk of neonatal jaundice is the first step in reducing risks. Here’s what you can do:
• Prioritise Prenatal Care: Regular check-ups help identify and address risks early.
• Focus on Nutrition: A healthy diet during pregnancy reduces the chances of low birth weight.
• Breastfeed Early and Often: Frequent feeding helps your baby process bilirubin more efficiently.
At Cloudnine, we’re more than just a hospital—we’re a partner in your parenting journey. By combining compassionate care with cutting-edge technology, we’re setting new standards in maternity and neonatal health. Our mission is to ensure that every baby— whether preterm, SGA or full-term— has the brightest possible start. Together, we can make every birth a celebration of health, joy and hope. Because at Cloudnine, your baby’s first chapter is where our story begins.
Cloudnine uses non-invasive bilirubin monitoring and advanced screening to detect neonatal jaundice early. We assess risk factors like gestational age and birth weight, ensuring timely intervention.
We provide targeted phototherapy for newborns and specialised NICU care for severe cases. Parents are also guided on early feeding to help reduce bilirubin levels naturally.
Cloudnine integrates machine learning for risk prediction, early screening and customised care. Our NICUs, advanced phototherapy, and parental education ensure the best outcomes for newborns.
